Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
The Glioma Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center treats a wide range of high-grade and low-grade gliomas, including diffuse intrinsic pontine gliomas, optic pathway gliomas, cerebellar low-grade astrocytomas, glioblastoma multiforme, and anaplastic astrocytomas. As one of the most highly funded brain tumor programs in the world, children who come to our program have access to unique clinical trials, in which they can receive the most recent gliomas treatments.
Dana-Farber/Boston Children’s is an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We offer, in one specialized program, the full spectrum of services that are needed for diagnosis, treatment and ongoing care of even the rarest and hard-to-treat conditions.
Treatment teams in the Glioma Program feature neuro-oncologists who are experts at treating gliomas. In addition, our team includes internationally recognized pediatric subspecialists, including neurologists, neurosurgeons and radiation oncologists.
Learn more about our Glioma Program on the Dana-Farber/Boston Children’s website.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”